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ABSTRACT                        The stability and capacity of antioxidant status during chronic diabetes seriously
influence the outcome of the long-term complications caused by oxidative stress. In the present
study we investigated the effects of chronic streptozotocin-induced diabetes on the parameters
of antioxidant status: activity of scavenging enzymes, gluthation-related and total antioxidant
capacity, and degree of lipid peroxidation. Changes in the activities of superoxide-dismutase
(SOD), glutathione peroxidase (GSH-Px), gluthatione reductase (GSH-R), and catalase, and in
the content of reduced gluthation (GSH), and oxidised gluthatione (GSSG), and in the ratio
of GSH/GSSG in blood samples were determined by means of biochemical methods. The degree
of lipid peroxidation was measured via thiobarbituric acid assay (TBARS). Hyperglycaemia,
ketosis and the accumulation of glycated proteins were estimated by measuring blood glucose,
3-OH-butirate, fructosamine and haemoglobin A1C. In the course of chronic insulin-dependent
diabetes, i.e. at 2 and 7 days, 10 weeks, and 6 and 8.5 months after streptozotocin injection,
hyperglycaemia slightly while ketosis markedly attenuated. Lipid peroxidation was also
attenuated. SOD activity decrease in the acute phase only. The activity of GSH-Px increased in
the early phase while that of GSH-R mostly decreased in the chronic phase. GSH and GSSG
concentrations moved into opposite direction in a time dependent manner. In conclusion, in
chronic diabetes an attenuation of severity of diabetes was present throughout the post-
injection period, which was well reflected in the improved antioxidant status and capacity.
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Diabetes mellitus is accompanied by hyperglycaemia and a
disturbed intracellular carbohydrate metabolism. Hypergly-
caemia generates glucose auto-oxidation and auto-oxidative
glycosylation of proteins, which may be considered as a
combined source of generation of an additional amount of
reactive oxygen species (ROS, Baynes 1991; Van Dam et
al.1995, 1996). The formation of oxygen free radicals in
diabetes results in an extra charge on the antioxidant capacity
of the organism and leads to complications in different tissues
including vascular bed (Giugliano et al. 1996).
One of the most prominent sources of oxygen free
radicals like superoxide and hydroxyl radicals (•O2- and •OH,
respectively) is the process of autooxidation of glucose into
enediols in the presence of transition metals (Wolff et al.
1991). The enhanced generation of ROS in diabetes acceler-
ates protein glycation, while glycated proteins become more
susceptible to oxidation leading to the accumulation of
advanced glycation endproducts (Bonnefont-Rousselot
2002). The ROS-scavenging capacity through the antioxidant
systems becomes insufficient in diabetes and a constant
oxidative stress develops. Oxidation of lipids, proteins and
other macromolecules like DNA become overt with time
during the development of diabetes. Lipid peroxides like
malonyldialdehyde are the most frequently used compounds
for the assessment of the degree of oxidative stress by
measuring thiobarbituric acid reactive substances (TBARS,
Ohkawa et al. 1979).
In the present study we investigated how the antioxidant
capacity in the blood changes during the course of chronic
diabetes in rats. Markers of the altered glucose metabolism,
i.e. blood glucose, 3-OH-butirate, fructosamine and haemo-
globin A1C were assayed for estimation of the severity of
diabetes. The activities of several scavenging enzymes were
also followed. Among them superoxide-dismutase (SOD),
glutathione peroxidase (GSH-Px), gluthatione reductase
(GSH-R), and catalase were selected. Regarding the endog-
enous antioxidant defence mechanisms the function of
glutathione system was selected and the concentrations of
reduced and oxidised glutathione (GSH and GSSG) were
measured in the red blood cells (RBC). Changes in concen-
tration of lipid peroxidation products in both RBC and
plasma were also estimated as TBARS levels. By this ap-
proach a relation between the severity of diabetes and the
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Sixty young adult male Wistar rats (250-300g) were divided
into two groups: chronic diabetes and control. The rats were
kept under standard laboratory conditions (12/12 h dark/light
cycle, lights on at 7.00, room temperature set on 21±1ºC,
controlled humidity). All experiments on rats were performed
in strict compliance with National Institutes of Health Guide
for Care and Use of Laboratory Animals (1985).
Diabetes was induced with injection of streptozotocin
(Sigma, St. Louis, MO, USA) into the tail vein in a dose of
60 mg/kg body weight. The control rats were injected with
saline. Twelve animals were sacrificed after different survival
periods at each time, at 2 and 7 days, 10 weeks, 6 and 8.5
months. From the 12 animals 6 were streptozotocin-treated
and 6 controls. At the conclusion of the experiment the rats
were deeply anaesthetised with chloral hydrate (375 mg/kg
body weight; Sigma) and blood was taken from the aorta
during exsanguination. Disodium-ethylenediamine-tetraac-
etate (EDTA, 1 mg/ml, Sigma) was added to blood samples
to prevent coagulation. In each case another blood sample
was taken without anticoagulation to obtain serum as well.
After a short storage at 4ºC (maximum 1/2 hour) the antico-
agulated blood samples were processed for centrifugation at
3,000 G for 10 min at 4ºC. The erythrocytes and plasma
fractions were processed separately afterwards. After 3 times
washing with ice-cold physiological saline the erythrocyte
fraction were hemolysed with distilled water reaching 10X




To monitor the development of diabetes several variables
were measured: serum glucose and fructosamine, plasma 3-
hydroxi-butyrate concentration and glycosylated haemoglo-
bin content in the whole blood. Blood glucose concentration
from serum was determined spectrophotometrically by a
Figure 1. Time course of hyperglycaemia (upper panel) and ketosis
(lower panel) in streptozotocin-induced chronic diabetes in rats. **
p<0.01, *** p<0.001 compared to controls (Student’s t-test).
Figure 2. Increment in glycated haemoglobin content (upper panel)
and in plasma fructosamine level (lower panel) in rats exposed to
streptozotocin injection, during the time of chronic diabetes. ***
p<0.001 compared to controls (Student’s t-test).
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GOD/POD/PAP kit, an enzymatic colorimetric method
assaying the reaction product at 505 nm (Trinder et al. 1969).
The plasma 3-OH-butyrate concentration was determined by
the method of McMurray et al. (1984) by a Randox-kit
(United Kingdom). The fuctosamine concentration of the
serum was measured by a commercially available kit
(Roche). The amount of glycated haemoglobin in whole
blood samples was measured after a chromatographic sepa-
ration on resin with a colorimetric method at 415 nm.
B) Antioxidant parameters
Assaying markers of antioxidant systems the haemoglobin
(Hb) content of hemolysates was determined by using
MINOS SPE Automate system (Roche, France). Among the
antioxidant enzymes the Cu/Zn-SOD activity was deter-
mined by the method of Mishra et al. (1972) and Matkovics
et al. (1977) based on the inhibition of superoxide (•O2-)-
dependent transformation of epinephrine to adrenochrome.
The adrenochrome was measured at 480 nm with Hitachi U-
2001 spectrophotometer on standard temperature of 32ºC
using the 2X-diluted haemolysate. Listing analytical steps
briefly, the haemolysate was extracted with
chloroform:ethanol = 1:2, the water phase was obtained after
centrifugation with 15,000 rpm for 10 min. The activity of
SOD was expressed in U/gHb. One unit of SOD activity
corresponds to a 50% inhibition of epinephrine-adreno-
chrome conversion.
Catalase activity of the red blood cells was measured by
the method of Beers et al. (1952) by means of monitoring the
rate of H2O2 consumption at 240 nm on 25ºC. The determi-
nation was carried out in the 100X-diluted hemolysates. The
activity of catalase was expressed in g H2O2 hydrolysed/min/
ml hemolysate at 25ºC.
GSH-Px activity was measured spectrophotometrically
by the method of Sedlak et al. (1968; 412 nm; Hitachi U-
2001 spectrophotometer) using the 10X-diluted hemolysate
by applying 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) in the
presence of cumene hydroperoxide as a cosubstrate. The
activity of GSH-Px was expressed in µmol GSH oxidised/
min/gHb at 37ºC.
GSH-R activity was determined by the method of
Bergmeyer (1963) from the 10X-diluted hemolysate. In this
Figure 3. Time dependent changes in red blood cell (RBC) SOD activity
(upper panel) and in catalase activity (lower panel) following
streptozotocin injection. * p<0.05, *** p <0.001 compared to controls
(Student’s t-test).
Figure 4. Changes in red blood cell GSH-Px and GSH-R enzyme
activities (upper and lower panels, respectively) in the course of
chronic diabetes after streptozotocin injection. * p<0.05,
** p<0.01 compared to controls (Student’s t-test).
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assay the oxidised form of glutathione is reduced to GSH by
GSH-R in the presence of reduced nicotinamide adenine
dinucleotide phosphate (NADPH), which serves as a H+
donor in the chemical reaction. The oxidation of NADPH
was followed spectrophotometrically (340 nm, Hitachi U-
2001 spectrophotometer) throughout a 3 min period. The
activity of GSH-R was expressed in µmol NADPH oxidised/
min/gHb at 37ºC.
The GSH content of the same hemolysate was measured
spectrophotometrically (412 nm, Hitachi U-2001 spectropho-
tometer), with DTNB, by the method of Beutler et al. (1963)
and Tietze (1969). The amount of GSH in the hemolysate was
expressed in nmol/gHb.
The determination of oxidised gluthatione in the hemoly-
sate was carried out by the method of Tietze (1969) on 25ºC,
applying a spectrophotometric measurement with the help of
DTNB (412 nm, Hitachi U-2001 spectrophotometer). The
amount of GSSG was expressed in nmol/gHb. Finally the
ratio of GHS/GSSG was also calculated.
The degree of lipid peroxidation was established by
estimation of the thiobarbituric acid reactive substance
(TBARS) concentrations in both erythrocytes and plasma.
The TBARS content was determined as described by
Ohkawa et al. (1979) and Yagi (1976) by using thiobarbituric
acid (Merck, Darmstadt, Germany). The TBARS product was
assayed by Hitachi U-2001 spectrophotometer at 532 nm.
The RBC and plasma TBARS contents were expressed in
nmol/gHb and nmol/ml plasma, respectively.
The ferric reducing ability of plasma (FRAP) as a mea-
sure of total antioxidant capacity was assayed by the method
of Benzie and Strain (1996). The FRAP values was obtained
with spectrophotometer measurements at 593 nm.
Results
Characteristics of chronic diabetes
Two days after streptozotocin treatment the blood glucose
level increased to the maximum measured throughout this
experiment (Fig. 1, upper panel). The serum concentration
of 3-OH-butirate was also high on the second day and
remained significantly higher during the entire course of the
Figure 5. Concentrations and ratio of GSH and GSSG in the red blood
cells in the course of chronic diabetes after streptozotocin injection.
** p<0.01 compared to controls (Student’s t-test).
Figure 6. Lipid peroxidation expressed as TBARS concentration in
red blood cells (upper panel) and in the plasma (lower panel) in rats
exposed to streptozotocin injection. * p<0.05,
** p<0.01, *** p <0.001 compared to controls (Student’s t-test).
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study (Fig. 1, lower panel). By the end of observation period
the glucose level decreased slightly and the 3-OH-butirate
concentration showed a more marked diminution, especially
at the 8.5 months time point. Those parameters, which reflect
accumulation in the molecular effects of chronically high
glucose level, i.e. glycated haemoglobin and fructosamine,
are shown in Figure 2. It is clearly visible that with time the
level of both parameters increased significantly.
Parameters of oxidative metabolic state
Activities of oxidative scavenging enzymes are summarised
in Figure 3. SOD activity slightly decreased in the acute
phase, up to 7 days of the experiment (upper panel). Catalase
activity varied throughout the experiment into opposite
directions, therefore, no clear change could be realised (lower
panel). Enzymes related to the oxidation-reduction circuit of
the GSH pathways, GSH-Px and GSH-R, showed also some
activity changes (Fig. 4). GSH-Px activity increased signifi-
cantly at day 7 as well as slightly at 10th week, while other
time periods the increment did not reach statistical signifi-
cance. GSH-R activity, contrary to GSH-Px, performed a
decrement from the sub-acute phase (day 7) on.
The concentrations of reduced and oxidised molecular
forms of glutathione, i.e. GSH and GSSG, as well as their
ratio are shown in Figure 5. During the acute phase (day 2)
GSH reduced significantly, but the level of this antioxidant
marker has been restored from day 7 on (Fig. 5, upper panel).
In case of GSSG at the beginning of the observation period
the major effect was visible at day 7. This tendency could be
seen up to the 10th week, but later the direction of change
reversed (Fig. 5, middle panel). The ratio of these two
parameters showed a decrease in the acute and sub-acute
phases and in the chronic period it tended to be increased
(Fig. 5, lower panel).
The degree of lipid peroxidation measured as TBARS
level in the RBC and plasma is demonstrated in Figure 6. In
the case of RBC a slight tendency of increase was visible
throughout of all experimental time-points (upper panel),
while in the plasma a marked increment was found in all time
periods (lower panel). The highest reaction was visible at day
2 and from day 7 the increment in plasma levels became
practically constant.
The parameter of the overall antioxidant capacity reflect-
ed in the plasma, i.e. the FRAP concentration, slightly
increased at day 7 and became significantly more pronounced
at the chronic phase.
Discussion
The main findings of this experiment are the followings. (a)
After streptozotocin injection in the acute phase of the
diabetes (2nd day) blood glucose level showed already a
maximum and was accompanied by a maximal production of
3-OH-butirate indicating that ketosis followed the acute
diabetes. By the end of the observation period the remarkable
decline in 3-OH-butirate indicated that the metabolic severity
of diabetes attenuated. (b) FRAP concentration, i.e. the total
antioxidant capacity showed an increment in the course of
diabetes, which is in accordance with the decline in ketosis.
(c) The glutathione (GSH) antioxidant system also has been
compensated throughout the time-period of chronic diabetes:
at the acute and subacute phase the ratio of GSH/GSSG
decreased, but in the chronic phase this ratio turned into
opposite direction and stayed elevated, indicating that the
concentration of the reduced form of glutathione could meet
the requirements of the increased oxidative stress. (d) The
activities of the scavenging enzymes also changed. SOD
declined temporarily but only in the acute phase. GSH-PX
activity increased at the acute and subacute phases, while
GSH-R activity declined in the advanced period of testing.
To combat ROS the organism has defence mechanisms of
enzymatic and non-enzymatic types. The first line of enzy-
matic defence against the superoxide radical is formed by the
superoxide dismutase enzymes (SOD). These enzymes
catalyse the diffusion-limited dismutation of superoxide to
hydrogen peroxide and oxygen. The cytosolic SOD enzyme
contains the metal ions copper and zinc (Cu/Zn-SOD).
Hydrogen peroxide in peroxisomes is metabolised by cata-
lase (Oshino and Chance 1977). For further metabolism of
cytosolic and mitochondrial hydrogen peroxide a selenium
containing scavenger enzyme glutathione peroxidase (GSH-
Px) plays an important function. GSH-Px catalyses a reaction
in which hydrogen peroxide is reduced to water at the
expense of reduced glutathione. The resulting oxidised
glutathione molecule is a dimer (GSSG) and is recycled and
reduced to GSH by the glutathione reductase enzyme (GSH-
R).
Figure 7. Total antioxidant capacity (FRAP) measured in the plasma




In the present study an initial decrement in Cu/Zn-SOD
activity was observed in the erythrocytes of diabetic rats
(days 2 and 7). By the 10th week and longer periods, however,
the activity tended to be higher. It is recognised that oxidative
stress inactivates SOD by its enzymatic product H2O2 (Salo
et al. 1990). At the same time superoxide radical is a signal
for increased genetic expression of SOD (Matsuyama et al.
1993). The available amount and activity of SOD, therefore,
is the subject of a balance between the production of enzyme
molecule and its degradation. As it was shown here this
balance shows a time dependent modulation in the course of
diabetes.
Two enzymes, GSH-Px and catalase, cooperate in the
degradation of H2O2. While catalase activity did not show
consistent changes, GSH-Px displayed an increment, espe-
cially at the acute and subacute phases. It is probable that the
increased activity of GSH-Px participated in the gradual but
moderate recovery from the acute phase of oxidative stress
caused by diabetes. In the very beginning of the diabetic
oxidative stress the concentration of GSH decreased, while
the oxidised form of glutathione (GSSG) increased. The
ration of GSH/GSSG, therefore, decreased at days 2 and 7.
In the more advanced periods of the present testing GSSG
concentration decreased and the ration of GSH/GSSG tended
to be increased. In conclusion, in the course of the obser-
vation period the glutathione defence system showed a
gradual compensatory increment in its capacity.
The chronic decrement in the activity of GSH-R during
prolonged diabetes found in the present study raises several
questions. Like SOD the enzymes included in the glutathione
redox cycle show susceptibility to oxidation and inactivation.
In patients with insulin-dependent diabetes mellitus the GSH
pathway enzymes proved to be susceptible to oxidation and
this susceptibility increased in poorly controlled diabetics
(Dincer et al. 2002). In our present study the activity of GSH-
Px was not decreased but only that of GSH-R. It might mean
that the GSH redox enzymes are differently sensitive to the
destructing action of oxygen radicals.
Lipid peroxidation was studied by measuring TBARS
concentration. In the erythrocytes TBARS level increased
only moderately but in the plasma a marked elevation could
be observed. TBARS concentration in the plasma decreased
in the course of observation period with some fluctuation.
This finding is in accordance with the idea that there is a
functional recovery, at least partial, in the antioxidant defence
systems in rats during long-term diabetes.
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